These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20160200)

  • 1. Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome.
    Eggers KM; Kempf T; Lagerqvist B; Lindahl B; Olofsson S; Jantzen F; Peter T; Allhoff T; Siegbahn A; Venge P; Wollert KC; Wallentin L
    Circ Cardiovasc Genet; 2010 Feb; 3(1):88-96. PubMed ID: 20160200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
    Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
    Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Lagerqvist B; Lindahl B; Olofsson S; Allhoff T; Peter T; Siegbahn A; Venge P; Drexler H; Wallentin L
    Circulation; 2007 Oct; 116(14):1540-8. PubMed ID: 17848615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    Circulation; 2007 Oct; 116(17):1907-14. PubMed ID: 17909103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM; Kempf T; Venge P; Wallentin L; Wollert KC; Lindahl B
    Am Heart J; 2010 Jul; 160(1):88-94. PubMed ID: 20598977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome.
    Fernández-Bergés D; Bertomeu-Gonzalez V; Sánchez PL; Cruz-Fernandez JM; Arroyo R; Barriales Álvarez V; Carrasco Sánchez FJ; Dalli E; Castro Beiras A; Kaski JC;
    Int J Cardiol; 2011 Jan; 146(2):219-24. PubMed ID: 20439123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between thrombolysis in myocardial infarction risk score and one-year outcomes for patients presenting at the emergency department with potential acute coronary syndrome.
    Weisenthal BM; Chang AM; Walsh KM; Collin MJ; Shofer FS; Hollander JE
    Am J Cardiol; 2010 Feb; 105(4):441-4. PubMed ID: 20152236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction.
    Kempf T; Björklund E; Olofsson S; Lindahl B; Allhoff T; Peter T; Tongers J; Wollert KC; Wallentin L
    Eur Heart J; 2007 Dec; 28(23):2858-65. PubMed ID: 17977844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between QRS duration and prognosis in non-ST-segment elevation acute coronary syndrome.
    Jiménez-Candil J; Cruz González I; Martín F; Pabón P; León V; Hernández J; Sánchez-Flores M; Moríñigo J; Ledesma C; Martín-Luengo C
    Int J Cardiol; 2008 May; 126(2):196-203. PubMed ID: 17498825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome.
    Iversen KK; Dalsgaard M; Teisner AS; Schoos M; Teisner B; Nielsen H; Clemmensen P; Grande P
    Am J Cardiol; 2009 Dec; 104(11):1465-71. PubMed ID: 19932776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes.
    Yan RT; Yan AT; Mahaffey KW; White HD; Pieper K; Sun JL; Pepine CJ; Biasucci LM; Gulba DC; Lopez-Sendon J; Goodman SG;
    Eur Heart J; 2010 Apr; 31(8):958-66. PubMed ID: 20034973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
    Fox KA; Clayton TC; Damman P; Pocock SJ; de Winter RJ; Tijssen JG; Lagerqvist B; Wallentin L;
    J Am Coll Cardiol; 2010 Jun; 55(22):2435-45. PubMed ID: 20359842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.